Skip to main content

ORIGINAL RESEARCH article

Front. Mol. Neurosci., 09 January 2018
Sec. Molecular Signalling and Pathways
Volume 10 - 2017 | https://doi.org/10.3389/fnmol.2017.00441

RETRACTED: Icariin Reduces Dopaminergic Neuronal Loss and Microglia-Mediated Inflammation in Vivo and in Vitro

Retracted

A retraction of this article was approved in:

  1. Retraction: Icariin Reduces Dopaminergic Neuronal Loss and Microglia-Mediated Inflammation in Vivo and in Vitro

    1. Read retraction
\r\nGuo-Qing Wang&#x; Dai-Di Li&#x; Chun Huang Di-Sheng Lu Chao Zhang Shao-Yu Zhou Jie LiuGuo-Qing Wang† Dai-Di Li† Chun Huang Di-Sheng Lu Chao Zhang Shao-Yu Zhou Jie LiuFeng Zhang Feng Zhang*
  • Joint International Research Laboratory of Ethnomedicine of Ministry of Education and Key Laboratory of Basic Pharmacology of Ministry of Education, Zunyi Medical University, Zunyi, China

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Wang G-Q, Li D-D, Huang C, Lu D-S, Zhang C, Zhou S-Y, Liu J and Zhang F (2018) Icariin Reduces Dopaminergic Neuronal Loss and Microglia-Mediated Inflammation in Vivo and in Vitro. Front. Mol. Neurosci. 10:441. doi: 10.3389/fnmol.2017.00441

Received: 31 October 2017; Accepted: 19 December 2017;
Published: 09 January 2018; Retracted: 11 June 2024.

Edited by:

Jean-Marc Taymans, Institut National de la Santé et de la Recherche Médicale, France

Reviewed by:

Anke Van Der Perren, KU Leuven, Belgium
Nicola B. Mercuri, Università degli Studi di Roma Tor Vergata, Italy

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.